FY25 — The Inflection Year: CORE Energy Systems delivered a near-doubling of revenue to ₹218 Cr (+93%), and grew PAT from ₹2.07 Cr to ₹18.5 Cr — a 794% jump. EPS surged from ₹9.58 to ₹75.82. This reflects genuine operational delivery: India's nuclear capex cycle is translating into real contract execution. Simultaneously, the company has signed a first-of-its-kind technology transfer agreement with Flowserve Corporation for Primary Coolant Pumps, and is publicly targeting ₹2,000 Cr revenue within 3 years.
Valuation Context: At ~20× FY25 revenue and ~231× FY25 EPS, CORE trades at a significant premium to listed EPC peers. The investment case rests on continued growth toward ₹2,000 Cr over FY27–29 as India's 18 new reactors move from planning to construction, PCP manufacturing scales, and eventual IPO re-rating. FY25 results materially strengthen — but do not complete — the earnings validation needed to justify current prices.
India's nuclear sector is undergoing its most significant expansion since inception. Installed capacity stands at 8.78 GW today, targeted to reach 22.4 GW by 2031-32 (18 new reactors), and an ambitious 100 GW by 2047. Total capex to achieve 100 GW is estimated at ₹8–12 lakh crore over two decades. CORE's FY25 revenue surge is an early signal that this capex has begun to flow.
Nuclear EPC in India is an oligopoly of credentials. BHEL and L&T operate at reactor-construction scale. In specialised engineering systems, fuel handling, and nuclear-grade component supply, CORE has almost no direct private-sector rival with equivalent AERB credentials, ISO 19443:2018 certification, and 22+ years of validated nuclear project track record. Each passing year makes this moat harder to replicate.
India's nuclear build-out remains subject to DAE timelines, budget allocations, and site clearances. PSU payment cycles of 120–180 days create structural working capital strain. Private sector participation under SHANTI Act (2025) is legally enabled but operationally nascent. SMR programme timelines remain aspirational — first deployment targeted 2033, but delays are possible.
India's 100 GW nuclear target requires 11× capacity growth. The ₹20,000 Cr Nuclear Energy Mission (Budget 2025-26) for SMR R&D is a direct demand driver. PFBR first criticality in April 2026 validated India's advanced reactor programme. SHANTI Act 2025 opens private sector participation. US-India 123 Civil Nuclear Agreement enables technology transfers like the Flowserve-CORE PCP deal.
| Segment | FY25 Rev (₹ Cr) | FY24 Rev (₹ Cr) | YoY % | Mix % | Seg PAT (₹ Cr) | PAT Margin |
|---|---|---|---|---|---|---|
| Construction Contracts | 166.44 | 78.43 | +112.3% | 77.5% | 17.28 | 10.38% |
| Maintenance Service | 25.75 | 27.75 | −7.2% | 12.0% | 0.77 | 3.00% |
| Supply & Erection | 22.46 | 6.67 | +236.7% | 10.5% | 2.08 | 9.26% |
| Total (Segment) | 214.65 | 112.85 | +90.2% | 100% | 20.13 | 9.38% |
₹ Crore. Source: CORE Energy Systems Annual Report FY2025, Note 30. Total segment ₹214.65 Cr; reported consolidated ₹218 Cr (difference: inter-segment eliminations).
| Particulars | FY23 | FY24 | FY25 | FY25 Growth | FY25 Margin |
|---|---|---|---|---|---|
| Revenue from Operations | 108.2 | 112.8 | 218.0 | +93.3% | — |
| Cost of Material Consumed | 64.0 | 12.4 | 92.0 | +642% | 42.2% |
| Change in Inventory | (11.3) | 6.0 | 3.2 | — | — |
| Gross Margin | 51.3 | 83.7 | 56.3 | −32.7% | 25.8% |
| Employee Benefit Expenses | 34.8 | 40.3 | 41.0 | +1.7% | 18.8% |
| Other Expenses | 19.0 | 37.7 | 54.0 | +43.2% | 24.8% |
| EBITDA | 1.7 | 16.4 | 27.8 | +69.5% | 12.75% |
| OPM (%) | 1.57% | 14.54% | 12.75% | −179 bps | — |
| Other Income | 2.8 | 2.6 | 7.0 | +169% | — |
| Finance Cost | 1.8 | 8.6 | 10.0 | +16.3% | — |
| D&A | 0.7 | 2.5 | 2.8 | +12% | — |
| EBIT | 1.0 | 13.9 | 25.0 | +79.9% | 11.47% |
| PBT | 2.1 | 7.76 | 22.2 | +186% | 10.18% |
| Tax | 0.7 | 5.69 | 3.7 | −34.9% | — |
| PAT | 1.4 | 2.07 | 18.5 | +794% | 8.49% |
| NPM (%) | 1.29% | 1.84% | 8.49% | +665 bps | — |
| EPS (₹) — Reported | 0.44 | 9.58 | 75.82 | +692% | — |
| EPS (₹) — Fully Diluted (24.83L sh.) | ~0.40 | ~8.35 | ~74.51 | +792% | — |
| Implied Mkt Cap @ ₹17,500 | — | — | ₹4,344 Cr | — | — |
| P/Revenue (FY25) | — | — | ~20× | — | — |
| P/E on Reported EPS | — | — | ~231× | — | — |
All figures ₹ Crore. Fully diluted EPS on 24,82,834 shares (post all PAS-3 allotments).
Key P&L Read: Revenue nearly doubled while EBITDA grew 70% — OPM compressed slightly from 14.54% to 12.75%, reflecting higher project execution costs at rapid scale. Finance cost increased to ₹10 Cr (from ₹8.6 Cr), indicating continued working capital intensity from PSU payment cycles. PAT of ₹18.5 Cr vs ₹2.07 Cr in FY24 is a genuine operational jump driven by construction contract execution — confirmed by audited segment data.
Business & Growth Metrics (FY25)
Valuation Metrics (Fully Diluted @ ₹17,500)
* If management achieves ₹2,000 Cr revenue within 3 years and the stock holds at ₹17,500, the implied P/Revenue of ~2.2× would be in line with listed EPC peers — making the long-term valuation case structurally compelling IF the revenue guidance is achieved.
| Company | Revenue | PAT Margin | Market Cap | P/Revenue | Nuclear Credentials | Status |
|---|---|---|---|---|---|---|
| CORE Energy Systems ★ (FY25) | ₹218 Cr | 8.49% | ~₹4,344 Cr | ~20× | AERB · ISO 19443 · Flowserve PCP | Pre-IPO |
| Walchandnagar Industries | ₹380 Cr | 3.2% | ~₹2,500 Cr | ~6.6× | Nuclear equipment supplier | ✅ Listed (BSE) |
| Ion Exchange (India) | ₹1,100 Cr | 7.1% | ~₹6,000 Cr | ~5.5× | Water treatment for nuclear | ✅ Listed (NSE) |
| Thermax | ₹8,700 Cr | 5.5% | ~₹20,500 Cr | ~2.3× | Industrial EPC — no nuclear | ✅ Listed (NSE) |
| BHEL (nuclear div.) | ₹28,000 Cr | 1.1% | ~₹70,000 Cr | ~2.5× | Full nuclear capability | ✅ Listed (NSE) |
| L&T (nuclear/power) | ₹2.2 L Cr | 6.8% | ~₹4.6 L Cr | ~2.1× | Nuclear reactor components | ✅ Listed (NSE) |
The Re-Rating Math: At FY25 revenue of ₹218 Cr, CORE trades at ~20× P/Revenue. If management achieves even 50% of their ₹2,000 Cr target (₹1,000 Cr by FY27-28), the implied P/Revenue at ₹17,500 falls to ~4.3× — approaching Walchandnagar and Ion Exchange territory. The Flowserve PCP deal adds a high-margin component manufacturing layer that could further justify re-rating at listing, shifting CORE's peer comparison toward precision manufacturing companies globally.
Kacholia is widely regarded as one of India's sharpest small-cap pickers. His ₹46.77 Cr bet — the largest single investor position in the Oct 2024 raise — signals deep conviction on the nuclear EPC theme. He typically does extensive due diligence before committing capital of this size to an unlisted company.
Two entirely independent sophisticated investors committing identical ₹46.77 Cr positions in the same round — with Kacholia as the other — is a strong peer-validation signal. This isn't coincidence; it reflects shared due diligence on CORE's moat.
| Investor | Amount | City |
|---|---|---|
| Praful Kumar | ₹14.99 Cr | Mumbai |
| Ritesh Dalmia & Archit Dalmia | ₹7.50 Cr | Kolkata |
| Naresh Saraaf | ₹5.00 Cr | Mumbai |
| Satyabrata Mohanty | ₹5.00 Cr | Mumbai |
| Satyen Vallbhabhbai Patel | ₹5.00 Cr | Pune |
| Sushil Kumar Jain | ₹5.00 Cr | Jaipur |
| Jaideep Goswami | ₹2.50 Cr | Mumbai |
| Amaara Ventures LLP | ₹2.00 Cr | Mumbai |
| AV Fincorp Pvt Ltd | ₹2.00 Cr | Mumbai |
| Jayshree Amol Taori | ₹2.00 Cr | Mumbai |
| Niraj Mansingka | ₹2.00 Cr | Mumbai |
| Sajit Raghava Suvarna | ₹2.00 Cr | Mumbai |
| Snehal Shah | ₹2.00 Cr | Mumbai |
| Tuljaram & Kamala Maheshwari | ₹2.00 Cr | Mumbai |
| Kailash Dinodia | ₹1.50 Cr | Surat |
| Seema Sanjay Agarwal | ₹1.50 Cr | Thane |
| Rajesh Agarwal | ₹1.00 Cr | Kolkata |
| Seema Chaudhary | ₹1.00 Cr | Dehradun |
| Tranche 1 Total — 88,146 shares | ₹63.99 Cr | — |
| Investor | Amount | City |
|---|---|---|
| ⭐Ashish Kacholia | ₹46.77 Cr | Mumbai |
| ⭐Ashish Agarwal & Navneet Agarwal | ₹46.77 Cr | Mumbai |
| Md Abdul Saleem | ₹3.99 Cr | Bangalore |
| Vikram Chirimar | ₹3.99 Cr | Kolkata |
| Satyabrata Mohanty | ₹2.50 Cr | Mumbai |
| Girish Sareen | ₹2.00 Cr | Delhi |
| Jayshree Amol Taori | ₹1.00 Cr | Mumbai |
| Akash Singh | ₹1.00 Cr | Mumbai |
| Anil Bhavanji Shah & Darshana Shah | ₹1.00 Cr | Mumbai |
| Anand Kumar Tiwari | ₹1.00 Cr | Kolkata |
| Ishita V Chirimar | ₹1.00 Cr | Kolkata |
| Ketan Kalyanchand Kotecha | ₹1.00 Cr | Pune |
| Rajulaben Nalinkumar Shah | ₹1.00 Cr | Ahmedabad |
| Shekhar Ravindra Sardessai | ₹1.00 Cr | Goa |
| Snehal Bhupendra Shah | ₹1.00 Cr | Mumbai |
| Sudip Kumar Agarwal | ₹1.00 Cr | Kolkata |
| Rajendra Senapati | ₹0.07 Cr | Pune |
| Tranche 2 Total — 1,59,910 shares | ₹116.09 Cr | — |
Context for new investors at ₹17,500: Ashish Kacholia and Ashish Agarwal entered at ₹7,260/share in Oct 2024 — a price 58% below current OTC levels. Their unrealised gain from that entry is ~₹10,240/share (+141%). The fact that these investors have not publicly exited despite the price appreciation signals continued conviction in the IPO re-rating thesis. However, new investors at ₹17,500 are effectively buying in at 2.4× the Kacholia entry price — making the margin of safety materially thinner.